Notably, MTA2 overexpression or PTEN knockdown confers resistance to the growth-suppressive effects of 10 μmol/L BITC but not 20 μmol/L BITC in the pancreatic cancer cells (Supplementary Figure 2). This evidence concerns the gene MTA2 and pancreatic neoplasm.